Back
Day Range
$7.55
$7.82
52-Week Range
$7.39
$16.79
Volume
9,748,379
50D / 200D Avg
$9.98
/
$12.00
Prev Close
$7.51
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -9.8 | 0.4 |
| P/B | 0.9 | 2.9 |
| ROE % | -9.2 | 3.8 |
| Net Margin % | -8.1 | 3.9 |
| Rev Growth 5Y % | -3.0 | 10.0 |
| D/E | 0.7 | 0.2 |
Key Takeaways
Revenue declined -2.95% annually over 5 years
Earnings declined -174.52% over the past year
Generating 495.00M in free cash flow
PEG of 0.08 suggests growth is underpriced
Capital efficient — spends only 1.97% of revenue on capex
Growth
Revenue Growth (5Y)
-2.95%
Revenue (1Y)-3.41%
Earnings (1Y)-174.52%
FCF Growth (3Y)-17.29%
Quality
Return on Equity
-9.20%
ROIC-1.94%
Net Margin-8.09%
Op. Margin-3.76%
Safety
Debt / Equity
0.71
Current Ratio1.78
Interest Coverage-1.45
Valuation
P/E Ratio
-9.76
P/B Ratio0.93
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -3.41% | Revenue Growth (3Y) | -3.02% |
| Earnings Growth (1Y) | -174.52% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2.95% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 6.55B | Net Income (TTM) | -530.20M |
| ROE | -9.20% | ROA | -4.50% |
| Gross Margin | 32.65% | Operating Margin | -3.76% |
| Net Margin | -8.09% | Free Cash Flow (TTM) | 495.00M |
| ROIC | -1.94% | FCF Growth (3Y) | -17.29% |
| Safety | |||
| Debt / Equity | 0.71 | Current Ratio | 1.78 |
| Interest Coverage | -1.45 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.76 | P/B Ratio | 0.93 |
| P/S Ratio | 0.79 | PEG Ratio | 0.08 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 5.18B | Enterprise Value | 8.76B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.55B | 6.78B | 6.97B | 7.51B | 7.39B |
| Net Income | -530.20M | 711.50M | 321.10M | 686.50M | 572.60M |
| EPS (Diluted) | -0.78 | 1.04 | 0.47 | 1.01 | 0.85 |
| Gross Profit | 2.14B | 2.28B | 2.36B | 2.60B | 2.50B |
| Operating Income | -246.20M | 1.08B | 696.40M | 1.13B | 972.20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 11.79B | 12.11B | 12.97B | 13.46B | 13.90B |
| Total Liabilities | 6.23B | 6.16B | 7.72B | 8.61B | 9.70B |
| Shareholders' Equity | 5.57B | 5.96B | 5.25B | 4.86B | 4.20B |
| Total Debt | 3.95B | 4.06B | 5.54B | 6.29B | 7.02B |
| Cash & Equivalents | 365.40M | 261.90M | 262.90M | 372.90M | 301.70M |
| Current Assets | 2.45B | 2.15B | 2.38B | 2.66B | 2.48B |
| Current Liabilities | 1.38B | 2.01B | 1.48B | 1.66B | 1.45B |